MesoTV Podcast: Conversations Impacting…

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

Site

RSS

Apple

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://www.curemeso.org/get-involved/mesotv/
6 partages
http://www.curemeso.org
2 partages
https://www.curemeso.org/mesotv.
2 partages

https://www.nature.com/articles/s41565-021-00961-w.
1 partage

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

MesoTV | Precision medicine for mesothelioma w/ Dr. Melina Marmarelis

Saison 6 · Épisode 2

jeudi 14 mars 2024 • Durée 23:03

Melina Marmarelis, MD, Thoracic Medical Oncologist, UPenn joins us for an interview about precision medicine. She discusses biomarker information, such as histology (currently most valuable), but also molecular testing such as NF2, MTAP, CDKN2A mutations that can be used when determining precision medicine treatments. Other topics discussed are BAP1 mutations, PDL1 expression, mutational burden, and oncolytic viruses. The interview is moderated by Julie White, BSN, OCN, RN who is the patient services director at the Mesothelioma Applied Research Foundation. More information is available at curemeso.org.

Lire plusRéduire

Chemotherapy for mesothelioma

Saison 6 · Épisode 1

mercredi 31 janvier 2024 • Durée 33:12

Michael Offin, MD, MSKCC, joins us for an informative session about chemotherapy drugs, their uses, side effects, and supportive medications.

Two patients talk about their mesothelioma diagnosis and subsequent treatment

Saison 4 · Épisode 9

mardi 1 novembre 2022 • Durée 35:31

In this episode, we are joined by two patients who recently received a mesothelioma diagnosis. They discuss their initial shock to hear the word "mesothelioma" and their subsequent efforts to find specialists experienced in treating their cancer.

Lire plusRéduire

MesoTV | Radiation therapy for mesothelioma

Saison 4 · Épisode 8

mercredi 6 avril 2022 • Durée 43:56

We are joined by a panel of radiation oncologists who specialize in mesothelioma: - Charles B. Simone, II, MD, FACRO, Research Professor, Chief Medical Officer, New York Proton Center - Andreas Rimner, MD, Director of Thoracic Radiation Oncology Research, Memorial Sloan Kettering Cancer Center - Kenneth Rosenzweig, MD, Professor and Chairman, Department of Radiation Oncology, Mount Sinai School of Medicine in New York They join us to discuss radiation therapy for the treatment of mesothelioma. Some areas discussed include: • Difference/similarities between photon, proton, external beam, IMRT, stereotactic body radiation • The palliative effect of radiation therapy • The side effects of radiation therapy and the different treatment options available • The feasibility of radiation therapy for pleural mesothelioma vs. peritoneal mesothelioma • The overview of a typical radiation procedure

Lire plusRéduire

MesoTV | Precision medicine and targeted therapies for mesothelioma with Dr. Hedy Kindler

Saison 4 · Épisode 7

lundi 28 mars 2022 • Durée 30:52

Dr. Hedy Kindler of the University of Chicago Medicine joins us to discuss precision medicine and targeted therapies for the treatment of mesothelioma. Dr. Kindler explains the mechanisms of action for several molecular pathways associated with tumor growth and/or inhibition. She also discusses three specific therapeutic options available through clinical trials like CPI-0209 and olaparib (PARP inhibitors) targeted at the BAP1 tumor mutation; and the VT3989 targeting the NF2 pathway. While these treatment options are still in early clinical trial phases, they target specific known tumor mutations, which makes them more precise than traditional chemotherapy treatment.

Lire plusRéduire

MesoTV | The ABCs of the CBCs (how to make sense of your complete blood count test)

Saison 4 · Épisode 6

jeudi 24 mars 2022 • Durée 15:00

A complete blood count test, best known as the CBC, is a tool used by physicians to determine some basic information about their patient's health. Learn more about what each value means in relation to the patient's health and treatment. In this interview we are joined by Buerkley Opalecky, MSN, RN, Ambulatory Oncology Clinical Nurse Educator, University of Chicago. Leading the interview is Shannon Sinclair, RN, BSN, OCN who is the on-staff mesothelioma expert at the Mesothelioma Applied Research Foundation.

Lire plusRéduire

MesoTV | NOW ENROLLING: Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

Saison 4 · Épisode 5

lundi 21 mars 2022 • Durée 22:49

We are joined by Dr. Aaron Mansfield of the Mayo Clinic to discuss a new, now enrolling, clinical trial for peritoneal mesothelioma that randomizes patients into two arms: an arm that receives chemotherapy + bevacizumab, and an arm that receives chemotherapy, bevacizumab and immunotherapy.

Lire plusRéduire

MesoTV | Optimizing nutrition for mesothelioma patients on and off treatment

Saison 4 · Épisode 4

mercredi 16 mars 2022 • Durée 18:45

[PLEASE FORGIVE OUR PET-CAUSED AUDIO ISSUES IN THE BEGINNING OF THE VIDEO] Shannon Sinclair, RN, OCN, the director of patient services of the Mesothelioma Applied Research Foundation, interviews Joanna Myers Casale, RD, CSO. Joanna Myers Casale, RD, CSO is a registered dietitian at the MD Anderson Cancer Center at Cooper in Camden, NJ. She earned a Bachelor of Science degree in Clinical Dietetics & Nutrition from the University of Pittsburgh where she graduated magna cum laude. Joanna is a board certified specialist in oncology nutrition by the Commission on Dietetic Registration.

Lire plusRéduire

MesoTV | Discussion about NIH natural history study of patients with malignant mesothelioma

Saison 4 · Épisode 3

lundi 14 mars 2022 • Durée 34:05

Dr. Raffit Hassan of the National Cancer Institute joins us for a conversation about his study called "Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma" that collects information from mesothelioma patients and their families in order to study their disease and risk for other cancers. Dr. Hassan looks to answer certain questions such as "why do certain patients do better than others?"

Lire plusRéduire

MesoTV | A 21-year mesothelioma survivor shares her story of diagnosis, treatment, and community

Saison 4 · Épisode 2

jeudi 10 mars 2022 • Durée 39:21

We are joined by Suellen Crano, a 21-year peritoneal mesothelioma survivor, who shares her story from the early stages of diagnosis and beyond. Suellen was diagnosed with mesothelioma in 2001 after several years of seeking a diagnosis. While not typical in many ways, Suellen's journey includes going from feeling alone, and not knowing any other patients for years, to finding a supportive community of patients and family members.

Lire plusRéduire

Podcasts et contenus similaires

Autres podcasts ou contenus associés partageant des thèmes ou audiences similaires.

MesoTV Podcast: Conversations Impacting the Mesothelioma Community – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts Similaires Basées sur le Contenu

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

MesoTV Podcast: Conversations Impacting the Mesothelioma Community – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Other11

Nature1

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Podcasts Similaires Basées sur le Contenu

Other11

Nature1

Apple Podcasts

Spotify